Trypanocidal action of eupomatenoid-5 is related to mitochondrion dysfunction and oxidative damage in Trypanosoma cruzi

• Autor(a) principal: Pelizzaro-Rocha, Karin Juliane
• Data de Publicação: 2011
• Outros Autores: Veiga-Santos, Phercyles, Lazarin-Bidoia, Danielle, Ueda-Nakamura, Tania, Dias Filho, Benedito Prado, Ximenes, Valdecir Farias [UNESP], Silva, Sueli Oliveira, Nakamura, Celso Vataru
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1016/j.micinf.2011.05.011; http://hdl.handle.net/11449/8789
• topic: Trypanosoma cruzi; Eupomatenoid-5; Antioxidant system

Because of its severe side effects and variable efficacy, the current treatment for Chagas disease is unsatisfactory. Natural compounds are good alternative chemotherapeutic agents for the treatment of this infection. Recently, our group reported the antiproliferative activity and morphological alterations in epimastigotes and intracellular amastigotes of Trypanosoma cruzi treated with eupomatenoid-5, a neolignan isolated from leaves of Piper regnellii var. pallescens. Here, we demonstrate that eupomatenoid-5 exhibited activity against trypomastigotes, the infective form of T cruzi (EC(50) 40.5 mu W), leading to ultrastructural alteration and lipoperoxidation in the cell membrane. Additionally, eupomatenoid-5 induced depolarization of the mitochondrial membrane, lipoperoxidation and increased G6PD activity in epimastigotes of T cruzi. These findings support the possibility that different mechanisms may be targeted, according to the form of the parasite, and that the plasma membrane and mitochondria are the structures that are most affected in trypomastigotes and epimastigotes, respectively. Thus, the trypanocidal action of eupomatenoid-5 may be associated with mitochondrial dysfunction and oxidative damage, which can trigger destructive effects on biological molecules of T cruzi, leading to parasite death. (C) 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.